InvestorsHub Logo
Followers 253
Posts 17905
Boards Moderated 0
Alias Born 01/19/2006

Re: None

Wednesday, 06/27/2018 4:19:05 PM

Wednesday, June 27, 2018 4:19:05 PM

Post# of 797
Didn't do much for share price today:

https://ih.advfn.com/p.php?pid=nmona&article=77756290

"BOULDER, Colo., June 27, 2018 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI™ capsules in combination with MEKTOVI® tablets for the treatment of patients with unresectable or metastatic melanoma with a BRAFV600E or BRAFV600K mutation, as detected by an FDA-approved test. BRAFTOVI is not indicated for the treatment of patients with wild-type BRAF melanoma....[more]"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ARRY News